Role of amplified genes in the production of autoantibodies

Blood

Volumn 93, Issue 7, 1999, Pages 2158-2166

  Brass, Nicole ^a   Rácz, Alexander ^a   Bauer, Christine ^a   Heckel, Dirk ^a   Sybrecht, Gerhard ^a   Meese, Eckart ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

ANTIBODY PRODUCTION; ARTICLE; CHROMOSOME ABERRATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GENE TARGETING; GENETIC LINKAGE; HUMAN; HUMAN TISSUE; LUNG CARCINOGENESIS; LUNG SQUAMOUS CELL CARCINOMA; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0344197154     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.7.2158     Document Type: Article

References (40)

1. Bos J: Ras oncogenes in human cancer: A review. Cancer Res 49:4682, 1989
2. Takahashi M, Chen W, Byrd DR, Disis ML, Huseby ES, Qin H, McCahill L, Nelson H, Shimada H, Okuno K, Yasutomi M, Peace DJ, Cheever A: Antibody to ras proteins in patients with colon cancer. Clin Cancer Res 1:1071, 1995
3. Winter SF, Minna JD, Johnson BE, Takahashi T, Gazdar AF, Carbone DP: Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation. Cancer Res 52:4168, 1992
4. Schlichtholz B, Legros Y, Gillet D, Gaillard C, Marty M, Lane D, Calvo F, Soussi T: The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot. Cancer Res 52:6380, 1992
5. Schlichtholz B, Tredaniel J, Lubin R, Zalcman G, Hirsch A, Soussi T: Analysis of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein. Br J Cancer 69:809, 1994
6. Tureci O, Sahin U, Schobert I, Koslowski M, Schmitt H, Schild HJ, Stenner F, Seitz G, Rammensee HG, Pfreundschuh M: The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res 56:4766, 1996
7. Pupa SM, Menard S, Andreola S, Colnaghi MI: Antibody response against the c-erbB-2 oncoprotein in breast carcinoma patients. Cancer Res 53:5864, 1993
8. Yamamoto A, Shimizu E, Ogura T, Sone S: Detection of auto-antibodies against L-myc oncogene products in sera from lung cancer patients. Int J Cancer 69:283, 1996
9. Brass N, Heckel D, Sahin U, Pfreundschuh M, Sybrecht GW, Meese E: Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma. Hum Mol Genet 6:33, 1997
10. Blanke CD, Johnson DH: Combined modality therapy in non-small cell lung cancer. Curr Opin Oncol 7:144, 1995
11. Nielsen JL, Walsh JT, Degen DR, Drabek DM, McGill JR, Von Hoff DD: Evidence of gene amplification in form of double minute chromosomes is frequently observed in lung cancer. Cancer Genet Cytogenet 65:120, 1993
12. Balsara BR, Sonoda G, Du Manoir S, Siegfried JM, Gabrielson E, Testa JR: Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas. Cancer Res 57:2116, 1997
13. Bishop JM: Molecular themes in oncogenes. Cell 64:235, 1991
14. Rochaix JD, Bird A, Bakken A: Ribosomal RNA gene amplification by rolling circles. J Mol Biol 87:473, 1974
15. Spradling AC: The organization and amplification of two clusters of Drosophila chorion genes. Cell 27:193, 1981
16. Sambrook J, Fritsch EI, Maniatis T: Molecular Cloning - A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989
17. Drwinga HL, Toji LH, Kim CH, Greene AE, Mulivor RA: NIGMS human/rodent somatic cell hybrid mapping panels 1 and 2. Genomics 16:311, 1993
18. Dubois BL, Naylor SL: Characterization of NIGMS human/rodent somatic cell hybrid panel 2 by PCR. Genomics 16:315, 1993
19. Brass N, Heckel D, Meese E: Comparative PCR: An improved method to detect gene amplification. Biotechniques 24:22, 1998
20. Yan R, Rhoads RE: Human protein synthesis initiation factor eIF-4gamma is encoded by a single gene (EIF4G) that maps to chromosome 3q27-qter. Genomics 26:394, 1995
21. Ohtsuka K: Cloning of a cDNA for heat-shock protein hsp 40, a human homologue of bacterial DnaJ. Biochem Biophys Res Commun 197:235, 1993
22. Heckel D, Comtesse N, Brass N, Blin N, Zang KD, Meese E: Novel immunogenic antigen homologous to hyaluronidase in meningioma. Hum Mol Genet 7:1859, 1998
23. Amakawa R, Jing W, Ozawa K, Matsunami N, Hamaguchi Y, Matsuda F, Kawaichi M, Honjo T: Human Jk recombination signal bind protein gene (IGKJRB): Comparison with its mouse homologue. Genomics 17:306, 1993
24. Jansen E, Meulemans SM, Orlans IC, Van de Ven WJ: The NNP-1 gene (D21S2056E), which encodes a novel nuclear protein, maps in close proximity to the cystatin B gene within the EPM1 and APECED critical region on 21q22.3. Genomics 42:336, 1997
25. Reed AL, Yamazaki H, Kaufman JD, Rubinstein Y, Murphy B, Johnson AC: Molecular cloning and characterization of a transcription regulator with homology to GC-binding factor. J Biol Chem 273:21594, 1998
26. Fujisawa K, Fujita A, Ishizaki T, Saito Y, Narumiya S: Identification of the Rho-binding domain of p160ROCK, a Rho-associated coiled-coil containing protein kinase. J Biol Chem 271:23022, 1996
27. Park J, Takeuchi A, Sharma S: Characterization of a new isoform of the NFAT (nuclear factor of activated T cells) gene family member NFATc. J Biol Chem 271:20914, 1996
28. Brass N, Ukena I, Remberger K, Mack U, Sybrecht GW, Meese E: DNA amplification on chromosome 3q26.1-q26.3 in squamous cell carcinoma of the lung detected by reverse chromosome painting. Eur J Cancer 32:1205, 1996
29. Morley SJ, Curtis PS, Pain VM: eIF4G: Translation's mystery factor begins to yield its secrets. RNA 3:1085, 1997
30. Hentze MW: eIF4G: A multipurpose ribosome adapter? Science 275:500, 1997
31. Fukuchi-Shimogori T, Ishii I, Kashiwagi K, Mashiba H, Ekimoto H, Igarashi K: Malignant transformation by overproduction of translation initiation factor eIF4G. Cancer Res 15:5041, 1997
32. Ishizaki T, Maekawa M, Fujisawa K, Okawa K, Iwamatsu A, Fujita A, Watanabe N, Saito Y, Kakizuka A, Morii N, Narumiya S: The small GTP-binding protein Rho binds to and activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase. EMBO J 15:1885, 1996
33. Hill CS, Wynne J, Treisman R: The Rho family GTPases RhoA, Rac1 and CDC42Hs regulate transcriptional activation by SRF. Cell 81:1159, 1995
34. Khosravi-Far R, Solski PA, Clark GJ, Kinch MS, Der CJ: Activation of Rac and Rho, and mitogen activated protein kinases, are required for ras transformation. Mol Cell Biol 15:6443, 1995
35. Becker J, Craig EA: Heat shock proteins as molecular chaperons. Eur J Biochem 219:11, 1994
36. Davidoff AM, Iglehart JF, Marks JR: Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancer. Proc Natl Acad Sci USA 89:3439, 1992
37. Kaur J, Srivastava A, Ralhan R: Serum p53 antibodies in patients with oral lesions: Correlation with p53/HSP70 complexes. Int J Cancer 74:609, 1997
38. Petersen I, Bujard M, Petersen S, Wolf G, Goeze A, Schwendel A, Langreck H, Gellert K, Reichel M, Just K, Du Manoir S, Cremer T, Dietel M, Ried T: Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res 57:2331, 1997
39. Brass N, Rácz A, Heckel D, Remberger K, Sybrecht GW, Meese EU: Amplification of the genes BCHE and SLC2A2 in 40% of squamous cell carcinoma of the lung. Cancer Res 57:2290, 1997
40. Peyrat JP, Bonneterre J, Lubin R, Vanlemmens L, Fournier J, Soussi T: Prognostic significance of circulating p53 antibodies in patients undergoing surgery for locoregional breast cancer. Lancet 345:621, 1995